Achieve Life Sciences (ACHV) Tops Q4 EPS by 5c

Achieve Life Sciences (NASDAQ: ACHV) reported Q4 EPS of ($0.26), $0.05 better than the analyst estimate of ($0.31).

For earnings history and earnings-related data on Achieve Life Sciences (ACHV) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• BIG3 Basketball to go public via Graf Global merger at $290 million
• Independent Bank receives regulatory approval for HCB Financial acquisition